Status:
NOT_YET_RECRUITING
The Key to Emotional Balance
Lead Sponsor:
TC Erciyes University
Collaborating Sponsors:
The Scientific and Technological Research Council of Turkey
Conditions:
The Key to Emotional Balance
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This randomized controlled experimental study aimed to evaluate the effects of the Key to Emotional Balance (KBA) psychoeducational program, based on the Balance Model of Positive Psychotherapy (PPT),...
Eligibility Criteria
Inclusion
- Having a diagnosis of bipolar I or bipolar II disorder according to the DSM-5.
- Being between 18 and 65 years of age.
- Being literate and having the cognitive capacity to participate in written questionnaires.
- Being in a stable mood/remission (neither severely manic nor severely depressed) at the start of the study.
- Being on medication or willing and able to comply with treatment.
- Voluntarily agreeing to participate in the study and signing the informed consent form.
Exclusion
- Being in an episode of acute mania or severe depression.
- Having a diagnosis of another serious psychiatric disorder such as schizophrenia, schizoaffective disorder, severe anxiety disorder, or obsessive-compulsive disorder (OCD).
- Cognitive impairments, such as dementia, severe cognitive impairment, or mental retardation, that would prevent participation in the recommended therapy.
- Individuals with a history of substance abuse within the last 6 months or ongoing active substance use.
- Individuals who have attempted suicide within the last 6 months or who currently have suicidal thoughts (patients at high risk of suicide).
- Refusal to attend regular therapy sessions or severe resistance to psychotherapy.
- Individuals who are not compliant with recommended medication for bipolar disorder.
- Serious medical problems or chronic conditions that would prevent recommended psychotherapy (e.g., uncontrolled epilepsy or serious cardiovascular disease).
- Inability to speak Turkish sufficiently to understand the questionnaires and therapeutic interventions or difficulty communicating.
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT07208721
Start Date
October 1 2025
End Date
September 1 2026
Last Update
October 6 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.